Elodie Gautier-Veyret (E Gautier-Veyret)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 14

Top Topics

End Stage Renal Disease

Intensive Care Unit

Rheumatoid Arthritis Patients

Top Venues

Journal of clinical medicine

Fundamental & clinical pharmacology

Antimicrobial agents and chemotherapy

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

C Arrivé, X Fonrose, Fabienne Thomas, G Roth, E Jacquet, A Brice, C Chirica, D Farneti, Coralie Frenoux, F Stanke-Labesque, Elodie Gautier-Veyret
Discrepancies between Dihydropyrimidine dehydrogenase phenotyping and genotyping: what are the explanatory factors? British journal of clinical pharmacology (2023)
Capucine Arrivé, Marvin Jacquet, Elodie Gautier-Veyret, Thomas Jouvé, Johan Noble, Dorothée Lombardo, Lionel Rostaing, Françoise Stanke-Labesque
Early Exposure of Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection to Tocilizumab-A Preliminary Study. Journal of clinical medicine 12 (22) (2023)
Maud Maillard, Manon Launay, Bernard Royer, Jérôme Guitton, Elodie Gautier-Veyret, Sophie Broutin, Camille Tron, Félicien Le Louedec, Joseph Ciccolini, Damien Richard, Hugo Alarcan, Vincent Haufroid, Naïma Tafzi, Antonin Schmitt, Marie-Christine Etienne-Grimaldi, Céline Narjoz, Fabienne Thomas, null null
Quantitative impact of pre-analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency. British journal of clinical pharmacology (2022)
Léa Bolcato, Anne Thiebaut-Bertrand, Françoise Stanke-Labesque, Elodie Gautier-Veyret
Variability of Isavuconazole Trough Concentrations during Longitudinal Therapeutic Drug Monitoring. Journal of clinical medicine 11 (19) (2022)
Laura Gomez, Diane Boegler, Chloé Epiard, Layli Alin, Julie Arata-Bardet, Yvan Caspar, Thierry Debillon, Françoise Stanke-Labesque, Elodie Gautier-Veyret
Implementation of a Vancomycin Dose-Optimization Protocol in Neonates: Impact on Vancomycin Exposure, Biological Parameters, and Clinical Outcomes. Antimicrobial agents and chemotherapy 66 (5) (2022)
Anaelle Chavant, Xavier Fonrose, Elodie Gautier-Veyret, Marie Noelle Hilleret, Matthieu Roustit, Francoise Stanke-Labesque
Variability of Tacrolimus Trough Concentration in Liver Transplant Patients: Which Role of Inflammation? Pharmaceutics 13 (11) (2021)
Aurélie Truffot, Elodie Gautier-Veyret, Athan Baillet, Jean-François Jourdil, Françoise Stanke-Labesque, Jacques-Eric Gottenberg
Variability of rituximab and tocilizumab trough concentrations in patients with rheumatoid arthritis. Fundamental & clinical pharmacology 35 (6) (2021)
Léa Bolcato, Charles Khouri, Anette Veringa, Jan Willem C Alffenaar, Takahiro Yamada, Takafumi Naito, Fabien Lamoureux, Xavier Fonrose, Françoise Stanke-Labesque, Elodie Gautier-Veyret
Combined Impact of Inflammation and Pharmacogenomic Variants on Voriconazole Trough Concentrations: A Meta-Analysis of Individual Data. Journal of clinical medicine 10 (10) (2021)
Aurélie Truffot, Thomas Jouvé, Johan Noble, Béatrice Bardy, Paolo Malvezzi, Lionel Rostaing, Françoise Stanke-Labesque, Elodie Gautier-Veyret
Tocilizumab Trough Levels Variability in Kidney-Transplant Candidates Undergoing Desensitization. Journal of clinical medicine 11 (1) (2021)
Jean-François Timsit, Elodie Gautier-Veyret, Minh Patrick Lê, Lila Bouadma, Olivier Andremont, Mathilde Neuville, Bruno Mourvillier, Romain Sonneville, Eric Magalhaes, Jordane Lebut, Aguila Radjou, Roland Smonig, Michel Wolff, Laurent Massias, Claire Dupuis, Jean François Timsit
Impact of Loading Dose of Caspofungin in Pharmacokinetic-Pharmacodynamic Target Attainment for Severe Candidiasis Infections in Patients in Intensive Care Units: the CASPOLOAD Study. Antimicrobial agents and chemotherapy 64 (12) (2020)
Elodie Gautier-Veyret, Anne Thiebaut-Bertrand, Matthieu Roustit, Léa Bolcato, Julie Depeisses, Mathilde Schacherer, Gabriel Schummer, Xavier Fonrose, Françoise Stanke-Labesque
Optimization of voriconazole therapy for treatment of invasive aspergillosis: Pharmacogenomics and inflammatory status need to be evaluated. British journal of clinical pharmacology 87 (6) (2020)
Elodie Gautier-Veyret, Léa Bolcato, Matthieu Roustit, Stéphanie Weiss, Julia Tonini, Marie-Pierre Brenier-Pinchart, Murielle Cornet, Anne Thiebaut-Bertrand, Françoise Stanke-Labesque
Treatment by Posaconazole Tablets, Compared to Posaconazole Suspension, Does Not Reduce Variability of Posaconazole Trough Concentrations. Antimicrobial agents and chemotherapy 63 (10) (2019)
Théo Willeman, Julia Tonini, Cécile Garnaud, Sébastien Bailly, Peggy Gandia, Françoise Stanke-Labesque, Danièle Maubon, Elodie Gautier-Veyret
Refining the therapeutic range of posaconazole and isavuconazole for efficient therapeutic drug monitoring using a bioassay approach. Fundamental & clinical pharmacology 34 (2) (2019)
Elodie Gautier-Veyret, Aurélie Truffot, Sébastien Bailly, Xavier Fonrose, Anne Thiebaut-Bertrand, Julia Tonini, Jean-Yves Cahn, Françoise Stanke-Labesque
Inflammation is a potential risk factor of voriconazole overdose in hematological patients. Fundamental & clinical pharmacology 33 (2) (2018)